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ABSTRACT
Purpose: Health-related quality of life (HRQoL) is
considered a representative outcome in the evaluation
of chronic disease management initiatives emphasizing
patient-centered care. We evaluated the association
between receipt of processes-of-care (PoC) for
diabetes and HRQoL.
Methods: This cross-sectional study used self-
reported data from non-institutionalized adults with
diabetes in a Swiss canton. Outcomes were the
physical/mental composites of the short form health
survey 12 (SF-12) physical composite score, mental
composite score (PCS, MCS) and the Audit of
Diabetes-Dependent Quality of Life (ADDQoL). Main
exposure variables were receipt of six PoC for diabetes
in the past 12 months, and the Patient Assessment of
Chronic Illness Care (PACIC) score. We performed
linear regressions to examine the association between
PoC, PACIC and the three composites of HRQoL.
Results: Mean age of the 519 patients was 64.5 years
(SD 11.3); 60% were male, 87% reported type 2 or
undetermined diabetes and 48% had diabetes for over
10 years. Mean HRQoL scores were SF-12 PCS: 43.4
(SD 10.5), SF-12 MCS: 47.0 (SD 11.2) and ADDQoL:
−1.6 (SD 1.6). In adjusted models including all six
PoC simultaneously, receipt of influenza vaccine was
associated with lower ADDQoL (β=−0.4, p≤0.01) and
foot examination was negatively associated with SF-12
PCS (β=−1.8, p≤0.05). There was no association or
trend towards a negative association when these PoC
were reported as combined measures. PACIC score
was associated only with the SF-12 MCS (β=1.6,
p≤0.05).
Conclusions: PoC for diabetes did not show a
consistent association with HRQoL in a cross-sectional
analysis. This may represent an effect lag time between
time of process received and health-related quality of
life. Further research is needed to study this complex
phenomenon.
BACKGROUND
The number of people living with diabetes
mellitus (DM) continues to rise, with an esti-
mated 371 million individuals around the
world who were affected by the illness in
2012.1 The consequences of diabetic illness,
such as blindness and kidney disease, place a
high toll on patients and the social system,
not only in terms of functional life years lost,
but also in terms of the morbidity that leads to
disability and decreased quality of life.1–4
Given the signiﬁcant impact of diabetes on
patient lives and the responsibility of disease
self-management on the individual with dia-
betes, health-related quality of life (HRQoL) is
acknowledged as an important outcome to
consider when developing and assessing
interventions targeting these patients.5
Furthermore, novel chronic disease manage-
ment initiatives emphasize a more ‘patient-
centered’ model,6 with increased attention to
patient reported outcome measures (PROMs)
such as HRQoL.7
However, although HRQoL is accepted as
a diabetes-relevant outcome, having demon-
strated positive associations with patients’
daily life-functioning, disease management
and prognosis,5 8–10 efforts for assessing the
quality of diabetes care have primarily
focused on the development and monitoring
of process measures and clinical outcomes.
For almost two decades, system initiatives in
the USA and across the globe have poured
Key messages
▸ In this study, processes of care for diabetes were
not consistently associated with health-related
quality of life when adjusting for patient and
disease characteristics.
▸ There was similarly no association or trend towards
a negative association when these processes of
care were analyzed as combined measures.
▸ These findings prompt further diabetes research
to focus on the effects of processes-of-care on
health-related quality of life and other patient-
reported outcomes, from a patient-centered per-
spective, taking a longitudinal approach.
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resources into the implementation of speciﬁc process
measures11–13 that improve relevant intermediate and
ultimate end points such as glycated hemoglobin
(HbA1C), and diabetic complications, comorbidities
and overall prognosis, respectively.12 14 15 However, it is
not yet known how these process measures affect
PROMs in patients with diabetes, such as HRQoL.
Since process indicators are accepted as measures of
high-quality diabetes care,16 we ask whether these estab-
lished measures also ultimately translate into an
improved patient-centered outcome. Therefore, the aim
of this study was to examine whether receipt of highly
utilized process(es)-of-care (PoC) measures was related
to the HRQoL in patients with diabetes. We hypothe-
sised that there would be a positive association between
patient’s receipt of PoC, as measured by individual and
combined measures and HRQoL outcomes.
METHODS
Study design
We used data from a cross-sectional survey of patients
with diabetes.
Setting, population and recruitment
In the fall of 2011 and summer of 2012, patients with
diabetes were recruited by community-based pharmacies
registered in the canton of Vaud, Switzerland, a large
French-speaking canton (state) with over 720 000 inhabi-
tants.17 Patients were eligible if they came to the phar-
macy with a prescription for oral hypoglycemics, insulin,
glucometer and/or glucometer strips and had a diagno-
sis of diabetes for at least 12 months, were aged ≥18 and
non-institutionalized. Patients not residing in the canton
of Vaud, not speaking or understanding French well
enough, or those presenting with obvious cognitive
impairment were excluded, as well as women with gesta-
tional diabetes. During this two-phase process, 85 phar-
macies agreed to help recruit patients for the study and
519 eligible patients consented to the study, and com-
pleted and returned the questionnaire. Further details
about recruitment and participation may be found in
the published study about the original survey.18
Measures
Data were self-reported and collected using a paper
mail-in survey that was given to patients during their visit
to the pharmacy. It addressed the following themes: dia-
betes illness and care management, lifestyle, health
status and sociodemographics.
Dependent variables
The main dependent variables of our study were two
HRQoL measures, one generic and one disease-speciﬁc:
the SF-12 and the Audit of Diabetes-Dependent Quality of
Life (ADDQoL), respectively. We considered the mental
composite score (MCS) and physical composite score
(PCS) of the SF-12 rating, which each range from 0
(worst) to 100 (best).19 The 19-item ADDQoL instru-
ment,20 21 which is highly tailored to important issues of
daily life for patients with diabetes, has been used among
various types of populations, and is considered one of the
few disease-speciﬁc tools with adequate psychometric
properties.22 23 The 19-item ADDQoL global score ranges
continuously from −9 (worst) to 3 (best). Validation ana-
lyses for this project of the present French for Switzerland
version showed a CFI (goodness-of-ﬁt index) of 0.80, and
a Cronbach’s α of at least 0.90 for all items.
Exposure variables
PoC: individual measures
Our main exposure variables were six individual PoC
that are routinely used to monitor quality of diabetes
care in practice and in research studies.12 24 The
diabetes-speciﬁc patient-reported process measures were:
HbA1C check (yes, 1×/year; yes>1×/year; no; unknown),
retinal eye examination by ophthalmologist (yes,<1 year
ago; yes, 1–2 years ago; yes, >2 years ago; never;
unknown), annual urine microalbuminuria screen (yes;
no; unknown), annual foot examination by physician
(yes; no; unknown), annual lipid test (yes; no;
unknown) and annual inﬂuenza vaccination (yes; no;
unknown). Owing to a skip question survey method,
receipt of HbA1c check was only asked to those report-
ing knowing what HbA1c was (HbA1c-aware). However,
multiple categories were created for the HbA1c PoC
variable, to include the patients who did not know about
HbA1c (HbA1c-unaware). The HbA1c variable categor-
ies were as follows: (1) HbA1c-aware and HbA1c was
checked; (2) HbA1c-aware and HbA1c was not checked;
(3) HbA1c-aware and do not know if HbA1c was
checked; (4) HbA1c-unaware (not HbA1c-aware or do
not know if HbA1c-aware). The reference category was
‘HbA1c-aware and HbA1c was not checked.’
PoC: combined measures
We also used two combined measures for the PoC indi-
cators.25 These combined measures were restricted to
HbA1c-aware patients with no missing data, since these
respondents were asked about HbA1c check and had
answered all of the other PoC questions. This means
that HbA1c-unaware patients and patients with missing
and ‘do not know’ answers for any other PoC were not
included in the following two combined measures:
1. Mean percentage of recommended care: the sum of
received PoC (number of ‘yes’ responses per
patient), divided by six possible processes.
2. Percentage of patients receiving all of recommended
care: percentage of patients receiving six process
measures (patients with all ‘yes’ responses), with ref-
erence to those not receiving all process measures
(patients with ‘no’ for any of the six indicators).
Patient Assessment of Chronic Illness Care measure
Our last exposure variable was the Patient Assessment of
Chronic Illness Care (PACIC) global score (range from
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1-never to 5-always), which was used as an overall PoC
measure, assessing to what extent current care is congru-
ent with the Chronic Care Model.26 It does not incorp-
orate the aforementioned PoC variables but, rather,
bases its metrics on an evidence-based theoretical frame-
work for chronic disease care.
Covariates
We considered other patient and clinical variables given
their potential confounding with the association between
PoC receipt and HRQoL.5 27–29 These variables included
(1) demographics: age, gender, education (primary, sec-
ondary, tertiary), quartiles of monthly income level in
CHF (≤3499, 3500–5499, 5500–9499, ≥9500), living com-
panion (lives with someone at home, yes/no), (2)
medical history: alcohol consumption (history of alcohol
problems, yes/no), smoking (currently smoking, yes/
no), body mass index (underweight/normal, overweight,
obese), physical inactivity (no physical activity, yes/no),
number of medical/psychiatric comorbidities and (3)
diabetes characteristics and disease severity: diabetes type
(type 2/undetermined, type 1), treatment (on insulin,
yes/no), diabetes complications (presence of at least one
of the following diabetes complications: cardiovascular
disease, stroke, retinopathy, chronic kidney insufﬁciency,
regular dialysis or kidney transplant, neuropathy, foot
ulcer/wound, lower extremity amputation and severe
hypoglycemia or hyperglycemia,) and duration of dia-
betes illness (10 years or more, yes/no). In order to not
lose cases in fully adjusted models, missing and ‘do not
know’ responses (if these two totaled over 10) were incor-
porated into a separate category for each variable.
Statistical analysis
First, we conducted descriptive analyses to describe the
population, as well as HRQoL scores and PoC received.
Next, we performed bivariate analyses to examine the
association between each of the three HRQoL outcomes
(SF12-MCS, SF12-PCS, ADDQoL) and each single PoC
indicator. Using the ANOVA test, we assessed whether
there were any differences in HRQoL mean scores
between respondents for each PoC indicator, comparing
report of receipt and no receipt of each PoC.
We then performed linear regressions of HRQoL out-
comes and PoC. First, crude linear regression models
for each of the three outcomes simultaneously included
the six individual PoC (no covariates). All models were
then adjusted for demographics, medical history and
diabetes characteristics variables. Second, we used the
two PoC combined measures and the PACIC to examine
the association with the three HRQoL outcomes, in
crude and adjusted models.
Finally, we performed a sensitivity analysis for the com-
bined PoC measures to include all patient cases. This
consisted of creating a combined measure to include
patients with missing data as well as HbA1c-unaware
patients who were not asked the HbA1c-receipt question
(because they responded ‘no’ or ‘do not know’ to
awareness about HbA1c). In this sensitivity analysis
(worst case scenario), the HbA1c-unaware patients were
assumed as not having an HbA1c screen. Similarly, all
patients with missing/‘do not know’ responses for each
of the other indicators were counted as ‘no’ answers,
thus giving a complete observation set of 519 patients
for this combined measure sensitivity analysis. The sum
of received PoC (number of ‘yes’ responses) was com-
puted. We then used this combined measure to examine
the association with the three HRQoL outcomes, in
crude and adjusted models.
Checks for linearity and colinearity were performed in
initial bivariate analyses. Residuals in each linear regres-
sion model were tested for normality and for homosce-
dasticity. We crosschecked all model results using
transformed versions of the dependent variables, and
these did not differ from the initial ﬁndings, nor did
they provide a better residual distribution, which con-
ﬁrmed results of the original models used. To take into
account the intragroup correlation of individuals within
pharmacies, the clustered sandwich estimator was used
to estimate the variance–covariance matrix (VCE).
STATAV.12.0 was used for all analyses.
Written informed consent was obtained from all parti-
cipants, and data were kept conﬁdential.
RESULTS
Description of the study population is shown in table 1.
Among respondents, mean age was 64.5 years and almost
60% were men. The majority had a high school equiva-
lent education or above (81%) and lived with someone at
home (73%). While 17% were current smokers, 47%
were classiﬁed as obese and nearly 30% were physically
inactive. The average number of comorbidities per
patient was 1.8. The majority of patients reported having
type 2 diabetes (67%), 12.7% reported type 1 diabetes;
diabetes type diagnosis was unknown by 20% of respon-
dents. Almost 50% required insulin treatment and close
to half self-reported at least one diabetes-related compli-
cation. The highest-reported diabetes complications were
eye problems (with attention to the retina; 18%), stroke
or ischemic heart disease (15%) and hypoglycemia or
hyperglycemia (11%). Finally, 48% of patients had had a
diabetes diagnosis of greater than 10 years.
Table 2 presents the HRQoL outcomes and PoC
results. Mean SF-12 MCS and PCS scores were 47.0 (SD
11.2) and 43.4 (SD 10.6), respectively, and mean
ADDQoL score was −1.6 (SD 1.6). For individual
process variables, about 98% of HbA1c-aware patients
had had at least one HbA1c screen during the past
12 months. During that same time period, while screen-
ing for lipids was similarly high (94.2%), around 60–
70% of the patients reported having received the other
four individual process indicators, with the lowest corre-
sponding to microalbuminuria screening (63.3%).
Combined PoC measures show that HbA1c-aware indivi-
duals received about 86% of the six PoC indicators
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considered, and about 40% of these patients received all
six PoC. Results of the combined sensitivity analysis con-
sidering all 519 patients showed that at least 18.9%
patients received six of the six processes-of-care; this is a
result that tests a ‘worst-case’, where HbA1c-unaware for
HbA1c, and missing and ‘don’t know’ responses for any
PoC receipt are considered as a ‘no’ answer.
The comparisons of mean HRQoL scores across cat-
egories of patients having reported (+) or not (−) a spe-
ciﬁc PoC are shown in table 3. Only a few comparisons
were statistically signiﬁcant. On the one hand, patients
who received the inﬂuenza vaccine compared to those
who did not, had lower ADDQoL scores (−1.7 vs −1.3,
respectively) and lower PCS scores (41.8 and 46.2,
respectively), and those receiving the retinal examin-
ation reported worse ADDQoL score (−1.7), compared
to those who did not receive this examination (−1.2).
On the other hand, patients with HbA1c checks
reported better ADDQoL than those who did not report
any HbA1c check during the past 12 months. Of note,
there were no signiﬁcant differences in HRQoL out-
comes between the HbA1c-aware and the HbA1c-
unaware groups (data not shown).
Crude and adjusted linear regressions of models
including all individual PoC (table 4) suggest that while
there were no associations between the receipt of single
PoC and SF-12 MCS, receiving a foot examination by a
physician was negatively associated with the SF-12 PCS
score (ie, worse HRQoL: β=−1.8) in the fully adjusted
model. Also, receipt of inﬂuenza vaccine was associated
with lower ADDQoL in crude and in adjusted models
(β=−0.4).
Regarding combined measures of PoC (table 5), there
was no association with HRQoL in the adjusted models.
However, the sensitivity test (‘worst case’) did show that
each additional PoC received was associated with a
decrease in ADDQoL score (β=−0.1).
Finally, PACIC was positively associated with HRQoL,
with an increase in the SF-12 MCS score (β=1.6) for
each additional point on the PACIC global score
(table 5).
DISCUSSION
The results of this study suggest that overall there were
no consistently signiﬁcant associations between patients’
self-report of receipt of diabetic PoC and HRQoL. In
fact, save for the PACIC score showing that care more
congruent with the Chronic Care Model was positively
associated with better SF-12 MCS score, and HbA1c
being positively associated with better ADDQoL global
score, there was either no association or a trend towards
the negative. The ﬁndings were similar when we tested
process indicators as combined measures.
These ﬁndings were somewhat unexpected since we
hypothesized that receipt of PoC would lead, ultimately,
to better clinical outcomes, and thus better HRQoL.
Indeed, PoC have been shown to improve diabetic clin-
ical markers such as HbA1c levels and cardiometabolic
risk factors,30 thereby decreasing morbidity and mortal-
ity.14 31 32 Since less morbid patients report a better
HRQoL,5 33 34 we expected to see a positive association
between PoC and HRQoL.
One possible reason for this discordance is that, in
fact, receipt of PoC does not always translate to an obser-
vation of improved clinical outcomes for diabetes. In the
third National Health and Nutrition Examination Survey
(NHANES III), rates of health services use and diabetic
complications screening and hyperglycemia, high-blood
pressure and cholesterol treatment/therapy in patients
with type 2 diabetes were high; however, despite the rise
of these indicators, health status and outcomes did not
reﬂect a signiﬁcant improvement.35 Hypotheses for this
ﬁnding included patient and healthcare system factors
that did not allow for appropriately meeting patients’
needs. Similarly, in the Translating Research Into Action
Table 1 Characteristics of included patients with diabetes
(n=519)
Demographics
Mean age (n=519) 64.5 (SD 11.3)
Male (n=519) 59.7%
Education (n=504)
Primary 18.9%
Secondary 56.2%
Tertiary 25.0%
Monthly income (CHF; n=486)
≤3499 21.2%
3500–5499 26.5%
5500–9499 27.8%
≥9500 17.3%
‘do not know’ 7.2%
Lives with someone (n=516) 73.2%
Medical history
Current smoker (n=509) 17.3%
History of alcohol problems (n=505) 5.9%
BMI (n=481)
Underweight 0.8%
Normal 17.1%
Overweight 35.3%
Obese 46.8%
Mean number of comorbidities (n=505) 1.8 (SD 1.3)
Physically inactive (n=494) 29.8%
Diabetes characteristics
Diabetes type 2 or undetermined (n=519) 87.3%
Diabetes requiring insulin (n=516) 48.8%
Any diabetes complications* (n=505) 46.7%
Diabetes duration (n=511, years)
1–5 27.6%
6–10 24.5%
11–15 18.6%
16–20 11.9%
over 20 17.4%
*At least one diabetes complication: cardiovascular disease,
stroke, retinopathy, chronic kidney insufficiency, dialysis,
neuropathy, ulcer, amputation and severe hypoglycemia or
hyperglycemia.
BMI, body mass index.
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(TRIAD) study, though an average of one additional
documented PoC for each patient in a group or plan
was associated with signiﬁcantly lower mean low-density
lipoprotein cholesterol levels, this was not observed
with HbA1c, systolic blood pressure or high-density-
lipoprotein cholesterol levels.24 Finally, in a review of 24
Table 2 HRQoL scores and processes-of-care among included patients with diabetes (n=519)
HRQoL outcomes (n) Mean (SD)
SF-12 MCS 496 47.0 (11.2)
SF-12 PCS 498 43.4(10.6)
ADDQoL 512 −1.6 (1.6)
Individual process-of-care (at least one check in last 12 months) Percentage that received process
Hemoglobin A1c among ‘aware’ patients 282 98.3
Lipid 513 94.2
Urine microalbumin 512 63.3
Foot examination by physician 510 66.5
Retinal eye examination (in last 24 months) 511 75.7
Flu vaccination 514 63.8
Combined process-of-care measures
Mean percentage of recommended care* 236 85.9
Percentage of patients receiving all care* 236 41.5
PACIC Mean (SD)
Global score 503 2.8 (0.95)
*Complete observations with no missing data (among HbA1c-aware patients only).
ADDQoL, Audit of Diabetes-Dependent Quality of Life; HRQoL, health-related quality of life; PACIC, Patient Assessment of Chronic Illness
Care; SF-12, short form-12
Table 3 HRQoL outcome across individual processes-of-care, for those reporting it as having been performed (+) or not (−)
Health-related quality of life measures
Mean (SD) Mean (SD)
PoC not reported (−) PoC reported (+) p Value*
Lipids
SF-12 MCS 48.4 (9.1) 46.9 (11.3) 0.68
SF-12 PCS 42.2 (11.8) 43.5 (10.5) 0.76
ADDQoL −1.5 (1.4) −1.6 (1.6) 0.77
Urine microalbumin
SF-12 MCS 46.6 (11.4) 47.4 (11.1) 0.54
SF-12 PCS 41.6 (9.8) 44.0 (10.6) 0.12
ADDQoL −1.5 (1.5) −1.6 (1.6) 0.48
Foot examination
SF-12 MCS 46.7 (11.0) 47.2 (11.2) 0.66
SF-12 PCS 44.1 (9.0) 43.1 (11.2) 0.59
ADDQoL −1.5 (1.4) −1.6 (1.6) 0.72
Retinal eye examination
SF-12 MCS 47.8 (10.6) 46.9 (11.3) 0.39
SF-12 PCS 43.8 (11.0) 43.2 (10.5) 0.38
ADDQoL −1.2 (1.5) −1.7 (1.6) 0.01
Hemoglobin A1c†
SF-12 MCS 42.0 (10.1) 46.6 (11.6) 0.64
SF-12 PCS 30.0 (14.9) 43.7 (10.9) 0.18
ADDQoL −2.8 (0.98) −1.8 (1.7) 0.01
Flu vaccination p value‡
SF-12 MCS 47.4 (10.9) 46.8 (11.3) 0.58
SF-12 PCS 46.2 (9.9) 41.8 (10.6) 0.000
ADDQoL −1.3 (1.3) −1.7 (1.7) 0.001
*F-test for ANOVA.
†Results displayed for HbA1c-aware patients only.
‡Two sample t tests with equal variances.
ADDQoL, Audit of Diabetes-Dependent Quality of Life; ANOVA, analysis of variance; HbA1c, glycated hemoglobin; MCS, mental composite
score; PCS, physical composite score; PoC, processes-of-care; SF-12, short form-12.
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studies looking at the association of diabetes
quality-of-care with surrogate and clinical outcomes,
high-quality studies speciﬁcally examining process indi-
cators (number of tests or visits) showed mostly incon-
sistent or negative associations.36 Perhaps we could not
ﬁnd an improvement in HRQoL because the patients
observed in this study did not clinically beneﬁt from the
PoC received at the time of the survey.
Another postulation is the confounding of severity of
disease with more intense PoC, and thus low HRQoL.
We did try to control for this by adjusting for diabetes-
speciﬁc characteristics and comorbidity; it is, however,
still possible that we did not sufﬁciently account for all
aspects of illness severity that are linked to lower
HRQoL. In addition, increased medical treatment (such
as increased doctor visits and medical testing) may lead
to patient worry and inconvenience, and decreased
patient HRQoL. Although we did not ﬁnd studies docu-
menting the effects of PoC on patient stress levels, the
intensiﬁcation of some medical treatment (such as the
Table 4 Linear regression models of HRQoL and individual processes-of-care in crude and adjusted models
HRQoL outcomes
MCS PCS ADDQoL
β= β= β=
Process indicators† Crude Adjusted Crude Adjusted Crude Adjusted
Lipids −2.6 −3.4 −0.05 2.1 −0.005 −0.03
Urine microalbumin 1.2 0.95 1.8 0.5 −0.1 0.05
Foot examination by physician 1.1 0.9 −1.5 −1.8* −0.1* 0.2
Retinal eye examination (in past 24 months) −0.7 −0.2 −0.5 1.1 −0.3 −0.2
Flu vaccination −0.3 −0.8 −4.2α −1.4 −0.4** −0.4**
Hemoglobin A1c‡
HbA1c-aware and HbA1c was checked 4.8 1.4 14.9* 3.5 1.2 0.3
HbA1c-aware and do not know if HbA1c was checked 1.5 −2.7 19.1* 4.6 2.2 0.8
HbA1c-unaware (not aware or do not know if aware of
HbA1c)
6.2 0.5 13.7* 3.8 1.6 0.4
Adjusted. R2 for full model 0.11 0.39 0.21
Crude model=all process indicator in one model, no other covariates.
Adjusted model=all process indicators+14 covariates (demographics, medical history and diabetes characteristics).
Covariates:
Demographics: Age, Male, Education levels, Income levels, Living companion.
Medical hx: hx of alcohol problems, smoker, BMI category, comorbidities, physical activity.
Diabetes: type 2 or undetermined, on insulin, DM complications, DM over 10 years.
*p≤0.05; **p≤0.01; αp≤0.001.
†Reference: no care received for individual process-of-care.
‡Reference: HbA1c-aware and did not receive HbA1c screen/check.
HbA1c, glycated hemoglobin; HRQoL, health-related quality of life.
Table 5 Crude and adjusted linear regression models of (1) HRQoL and combined processes-of-care, (2) HRQoL and
PACIC, in crude and adjusted models
HRQoL outcomes
MCS PCS ADDQoL
Crude Adjusted Crude Adjusted Crude Adjusted
Mean percentage of recommended care† 5.9 4.5 −4.0 −2.1 −1.4 −0.8
Adjusted R2 for full model 0.18 0.35 0.19
Receiving all recommended care† 0.3 0.1 −0.7 0.1 −0.4 −0.2
Adjusted R2 for full model 0.17 0.35 0.19
Sensitivity analysis‡ −0.1 0.2 −0.4 −0.3 −0.2 −0.1*
Adjusted R2 for full model 0.12 0.39 0.21
PACIC score 0.96 1.6* 0.5 −0.6 −0.1 −0.1
Adjusted R2 for full model 0.13 0.39 0.20
Crude model=combined process-of-care measure, no other covariates.
Adjusted model=combined measure +14 covariates (demographics, medical history and diabetes characteristics).
Covariates:
Demographics: Age, Male, Education levels, Income levels, Living companion.
Medical hx: hx of alcohol problems, smoker, BMI category, co-morbidities, physical activity.
Diabetes: type 2 or undetermined, on insulin, DM complications, DM over 10 years.
*p≤0.05.
†Complete case: yes=1; no=0; all other answers=missing.
‡Worst case: yes=1; all other answers (HbA1c-unaware for HbA1c; no, missing, do not know for all other PoC)=0.
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transition from oral hypoglycemics to insulin) has been
linked to higher stress and worry and lower HRQoL
among patients with type 2 diabetes, though this rela-
tionship was inconsistent.5
One more readily possible explanation is that the lack of
association represents an effect lag time between time of
process received and impact on HRQoL; cross-sectional
data are not ideal to detect such an effect. Other studies
have also described the need to measure quality of care
and patient outcomes, over time, in order to most accur-
ately reﬂect these relationships.10 37 38 As such, the rela-
tionship between PoC and HRQoL might be further
elucidated through a longitudinal examination, and thus
should be a priority for future diabetic cohort studies.
Owing to this possible time-effect issue, one postulation
was that receipt of PoC could be associated with a more
immediate surrogate of patients’ experiences, such as
patient satisfaction. For example, the TRIAD study showed
that the number of care processes documented was asso-
ciated with patient satisfaction measures and self-rated
quality of diabetes care.24 In post hoc analyses, we indeed
observed a similar positive trend between PoC and ‘very
good/excellent’ patient ratings on care satisfaction (vs
‘bad/medium/good’) and feeling ‘very well/well informed’
(vs ‘very bad/bad/medium’), across individual and com-
bined PoC measures, as well as the PACIC global score.
This study is unique in that we attempted to examine
the speciﬁc association between PoC and HRQoL
among a population-based sample of patients with dia-
betes, a topic that, to the best of our knowledge, has not
yet been studied. We employed generic as well as
diabetes-speciﬁc HRQoL outcomes, and a range of
measurement for PoC (individual, combined, PACIC).
However, our results need to be interpreted in light of
the following limitations. First, since we used a cross-
sectional design, we cannot make conclusions about
causal associations even though exposure to PoC was
measured, retrospectively, for the previous year(s).
Second, our sample size, calculated for getting appropri-
ate precision around our primary outcomes, may have
been too small to detect signiﬁcant associations in sec-
ondary analysis. Another sample issue is that our com-
bined analyses were limited to 236 of the 519 patients
because of the skip question method for the question of
HbA1c check receipt. In order to not eliminate the
HbA1c-unaware patients from the combined measures,
we constructed a third measure that was tested in the
analysis where patients who responded ‘no’ or ‘do not
know’ to knowing about HbA1c were assumed to not
have received an HbA1c screen. A further point to con-
sider is the relation between PoC measures and quality
of life for patients with a speciﬁc complication (ie, how
is quality of life affected in patients with retinopathy who
receive an annual retinal examination compared to
patients with diabetes who do not have retinopathy and
receive annual retinal examinations?). Unfortunately,
the sample size for many of these speciﬁc complication
groups is much too small for further reliable analysis.
Third, the generalizability of these results is limited
because the studied population may not be representa-
tive of the true population of patients with diabetes. We
are nevertheless conﬁdent that our population-based
sampling method, which utilized community pharmacies
in the recruitment process, ensured the representative-
ness of patients with diabetes in the community (not just
in clinic and hospital settings). Furthermore, character-
istics of our patients with diabetes were similar to those
reported from a population-based cohort study con-
ducted in the same area.39 Last, we used self-reported
data that may be prone to recall bias; however, supple-
mentary analyses for this project demonstrated good cor-
relation between patient-reported data and physician
records for simple PoC, when data was supplied by the
treating physician for a fraction of the cohort.40
In conclusion, further research should focus on the
effects of PoC on patient-reported outcomes, particularly
from a patient-centered perspective. Our study probes
healthcare stakeholders to look beyond the presence of
PoC procedures as the sole measurement of ‘good care.’
Additional studies, speciﬁcally with longitudinal data, are
needed to examine the way in which PoC will translate
into better health for patients with diabetes and, ultim-
ately, a better quality of life. This includes looking into
the way these PoC are conducted, how often they are
delivered and what clinical cut-offs are being used.
Although our study is a ‘ﬁrst look,’ and more investiga-
tion is needed, we demonstrated that a list of achieved
PoC is not a simple surrogate for gauging improvement
on patient quality of life. Health systems and providers
must ensure that diabetic care resources are allocated
appropriately and organized effectively, so that patients
with diabetes are able to thrive in life despite their illness.
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